SCHD Is Brilliant. Here's Why I Think This Dividend ETF Is Even Better.
Source: Nasdaq

First Trust Rising Dividend Achievers ETF (RDVY) delivered a 15.8% average annual total return over the past decade, ahead of Schwab U.S. Dividend Equity ETF's (SCHD) 13.2%. RDVY emphasizes faster-growing Nasdaq dividend payers, with 30% financials, 26% technology, and a 0.8% trailing yield, while SCHD targets higher-income dividend growers with a 3.0% yield and heavier healthcare, consumer-staples, and energy exposure. The article favors RDVY for long-term wealth compounding and SCHD for investors prioritizing current dividend income.
Analysis
The relevant allocation question is not dividend yield but factor exposure: RDVY is effectively a financials/semiconductors/industrials growth basket with a dividend-quality screen, while SCHD is a defensive value-and-income basket. Its historical excess return is therefore unlikely to persist if long-end yields rise, credit conditions tighten, or AI-led semiconductor multiples mean-revert; RDVY would suffer both earnings-beta and valuation-beta compression. Conversely, a soft-landing regime with falling policy rates and continued capex strength favors RDVY's cyclical holdings, whereas SCHD's staples exposure faces limited volume growth and continued private-label pressure.
The article is unlikely to move either ETF, but it can reinforce retail flow into the recent-return winner. That is a marginal positive for META and NVDA, although ETF ownership is immaterial relative to their index and institutional flows. The more actionable implication is that investors seeking dividend-growth exposure should avoid treating RDVY as a low-volatility income substitute: its low yield offers little carry cushion in a drawdown, while SCHD's concentration in defensives and energy makes it more exposed to a disinflationary oil-price decline. Over 6-18 months, dividend growth should be judged against payout durability, buyback-adjusted capital return, and free-cash-flow conversion rather than trailing total-return comparisons.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.28
Ticker Sentiment
Key Decisions for Investors
- No standalone event trade: the article's low-impact, retail-facing framing is insufficient to justify ETF directional exposure before validating current RDVY/SCHD relative valuation, flows, and factor betas.
- For a 1-3 month soft-landing expression, consider a modest long RDVY / short SCHD pair rather than outright long RDVY; the trade isolates growth/cyclical dividend growers from defensive income. Target a 5-8% relative gain; exit if 10-year Treasury yields rise more than 35-50bp or semiconductor guidance weakens.
- For a 6-18 month defensive allocation, retain SCHD exposure but hedge its staples concentration through an underweight in PEP and PG versus broader quality; sustained volume declines, increased promotional spending, or a sharper-than-expected fall in energy prices would pressure SCHD's earnings mix.
- Treat META and NVDA as earnings-driven rather than dividend-theme beneficiaries. Maintain exposure only if forward revenue estimates continue rising; a material AI capex monetization miss or downward 2027 consensus revisions would invalidate the RDVY growth-premium thesis and favor closing the RDVY/SCHD spread.
More News
- Nvidia Is Weighing a $10 Billion Stake in Anthropic's IPO. It Would Be Buying Its Own Demand.
- Can Cloudflare CEO Matthew Prince save the web from AI?
- Major Milestone Passed In Iridium/Rocket Lab Tie Up
- 2 Healthcare Stocks That Just Delivered Great News for Investors
- Anthropic's IPO Was Just Delayed to November. Here's the One Number That Has Me Even More Excited.
- MP Materials Ships Its First Magnets to GM in Q4. This is What The Milestone Is Worth.